SCHEMBL1009532

SCHEMBL1009532

N#Cc1ccc(-n2ccnc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.58
MAPT P10636 1/20 0.58
ENPP2 Q13822 1/20 0.58
MKNK1 Q9BUB5 1/20 0.58
MKNK2 Q9HBH9 1/20 0.58
NOTUM Q6P988 1/20 0.58
CYP3A4 P08684 4/20 0.57
MEN1 O00255 1/20 0.55
ALOX15 P16050 1/20 0.55
TSHR P16473 1/20 0.55
KMT2A Q03164 1/20 0.55
CYP19A1 P11511 8/20 0.53
CYP11B1 P15538 2/20 0.53
CYP11B2 P19099 2/20 0.53
CYP1A2 P05177 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
GAA P10253 1/20 0.51
BAZ2B Q9UIF8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29115906 0.98 LMNA (0.56) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL17629992 0.95 MEN1 (0.64) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL25252707 0.84 CYP2D6 (0.56) LMNAENPP2MKNK1MKNK2CYP3A4
SCHEMBL2532397 0.83 LMNA (0.78) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL17629926 0.82 ADH5 (0.62) CYP3A4MEN1ALOX15TSHRKMT2A
SCHEMBL17630077 0.82 CYP11B1 (0.56) LMNAMAPTENPP2MKNK1MKNK2
Hydrochloric Acid SCHEMBL28701756 0.81 LMNA (0.75) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL2323776 0.81 LMNA (0.58) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL22745375 0.81 CYP3A4 (0.47) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL31606763 0.81 LMNA (0.58) LMNAMAPTENPP2MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930672-A Small molecular ionic liquid monomer adhesive and preparation method thereof 中国人民解放军国防科技大学 2025-05-06 CN claimed
CN-117567973-B High Tg underfill and preparation method thereof 深圳先进电子材料国际创新研究院 2024-04-09 CN claimed
CN-117567973-A High Tg underfill and preparation method thereof 深圳先进电子材料国际创新研究院 2024-02-20 CN claimed
CN-104448700-B Resin combination 味之素株式会社 2019-01-22 CN claimed
CN-104448700-A Resin composition AJINOMOTO KK 2015-03-25 CN claimed
EP-4509574-B1 ADHESIVE AGENT FOR MEDICAL DEVICES, CURED ARTICLE, MEDICAL DEVICE MEMBER, MEDICAL DEVICE, AND METHOD FOR MANUFACTURING MEDICAL DEVICE FUJIFILM CORP (JP) 2026-04-22 EP disclosed
CN-119930672-A Small molecular ionic liquid monomer adhesive and preparation method thereof 中国人民解放军国防科技大学 2025-05-06 CN disclosed
EP-4509574-A1 ADHESIVE AGENT FOR MEDICAL DEVICES, CURED ARTICLE, MEDICAL DEVICE MEMBER, MEDICAL DEVICE, AND METHOD FOR MANUFACTURING MEDICAL DEVICE FUJIFILM Corporation (JP) 2025-02-19 EP disclosed
US-20250019580-A1 ADHESIVE FOR MEDICAL DEVICE, CURED SUBSTANCE, MEDICAL DEVICE MEMBER, MEDICAL DEVICE, AND MANUFACTURING METHOD OF MEDICAL DEVICE FUJIFILM CORPORATION (JP) 2025-01-16 US disclosed
CN-118871544-A Adhesive for medical device, cured product, medical device component, medical device, and method for producing medical device 富士胶片株式会社 2024-10-29 CN disclosed
US-11980086-B2 Use of transition metal carbene complexes in organic light-emitting diodes (OLEDs) UDC IRELAND LIMITED (IE) 2024-05-07 US disclosed
US-11980086-B2 Use of transition metal carbene complexes in organic light-emitting diodes (OLEDs) UDC IRELAND LIMITED (IE) 2024-05-07 US disclosed
US-5736548-A CYCLIC GUANOSINE 3*,5*-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS; TREATING HEART FAILURE, HYPERTENSION SANOFI (FR) 1998-04-07 US disclosed
CN-1177963-A 6-arylpyrazolo [3, 4-d ] pyrimidin-4-ones and compositions and methods of use thereof SANOFI WINTHROP INC (US) 1998-04-01 CN disclosed
EP-0784612-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-07-23 EP disclosed
WO-1996028448-A1 6-ARYL PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 WO disclosed
WO-1996010559-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-11 WO disclosed
EP-0003560-B1 IMIDAZOLE DERIVATIVES AND SALTS THEREOF, THEIR SYNTHESIS, AND PHARMACEUTICAL FORMULATIONS THE WELLCOME FOUNDATION LIMITED (GB) 1984-05-02 EP disclosed
US-4431815-A CARDIOTONIC AND ANTISHOCK AGENTS; ANTICOAGULANTS BURROUGHS WELLCOME CO. (US) 1984-02-14 US disclosed
EP-0003560-A2 Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations THE WELLCOME FOUNDATION LIMITED (GB) 1979-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11980086-B2 Use of transition metal carbene complexes in organic light-emitting diodes (OLEDs) OCIAD2, OCIAD1, ICOSLG LMNA 3223/4885MAPT 414/4885ENPP2 2685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.